What would a single US science agency look like?

Imagine the impossible: the ability to reform America’s patchwork of science agencies into a single agency that would fund basic, applied, and translational research for academic institutions and teaching hospitals. That same agency would conduct intramural research at all US national labs and the current NIH Bethesda campus. The waterfront would extend from particle physics to cancer to planetary probes. What characteristics would it have in an ideal world?

First, it would have a high tolerance for scientific risk (this is quite different from business risk). So, we would want decision makers to have excellent scientific taste and some mix of advisory counsel from the community on both the quality of the investigator and the proposed work. Notably, there would be no pay line or algorithm against which to use game theoretic approaches. If the review was project-based, the philosophy would be to fund the entire project, not some a la carte menu-picking.

Second, the intramural component would have an explicit mission different from the extramural component: perhaps a higher tolerance for risk or a willingness to fund investigators and trust them to find suitable projects.

Third, we’d want to explicitly encourage and reward the dissemination of negative results and confirmatory studies. Perhaps we’d have a national lab dedicated to this mission alone?

Fourth, we’d want to prime the STEM labor pipeline with evidence-based approaches that explicitly track individuals through their training and into their careers. So think ORCID on steroids, from k-50+, in combination with adjusting to what works based on the data.

Finally, we’d want to vigorously promote science that breaks with groupthink, particularly in biomedical fields where progress has been unsatisfactory. The idea would be to create an ecosystem where progress is not measured in the funerals of senior thought leaders. This would require altering the US academic promotion and tenure architecture because that system currently kills off novel ideas through tenure denial or self-censorship.

Where would this agency live? As an independent agency, I think–one that would merge NASA, NSF, and NIH with DOE’s science operations. Its director would be nominated by the President and confirmed by the Senate. There would be no NSB or PCAST; the National Academies would provide advisory oversight to complement Congress, OMB, and the GAO.

And the budget: it would ideally be provided in multiyear chunks analogous to the way the US procures submarines and aircraft carriers: the goal to provide stability, even at the cost of growth.

Vanevar Bush imagined such an agency in Science the Endless Frontier. Politics created the patchwork we have.

At Duke University…

Window view from JP Duke Hotel, Durham NC

I’ve been to the Research Triangle several times, but this is the first time I’ve set foot on this campus. I’m participating in a faculty seminar that encourages civil discourse in our classrooms. What a good idea! At Amherst College, even at the height of the Vietnam War, I vividly recall very strong opinions but no uncivil behavior. There was definitely civil disobedience, but it was respectful.

As faculty participants, we come from institutions of all types across this country. I’ll be looking forward to learning from my colleagues.

My new book contract…

I’m working on a book about becoming a scientist who is also a public intellectual. Kind of the story of my professional life since I ‘graduated’ from being a postdoc at the NIH. Yesterday, I signed a book contract with Elgar. I’m really jazzed about this project and I’ll keep you up to date as things progress.

Last day of classes: Spring semester

This was a particularly enjoyable semester for me. Lots of very smart students (both grad and undergrad), and I learned some new tricks for teaching more effectively. George Mason has a new provost and a new logo. On the latter, my students weren’t too enthusiastic. But I think we got a good one on the former. I’m pleased to see our leadership team’s roots in the University of California system.

My new book project about scientists as public intellectuals is moving forward at full speed this summer. I’m also looking forward to revisiting Australia (see photo).

U Chicago’s Money Issues…

The Chronicle has a pretty comprehensive look. It’s not a pretty picture. And the MBL ‘acquisition’ has an uncomfortable high profile in the piece. I respect UC–it does a lot of things better, but it will have to make some tough decisions. Interestingly, what started with a couple of high-profile public R1s now seems to be spreading to the privates.

Most science is expensive…

Photo by FOX on Pexels.com

My folks (they were both scientists also) used to drill into my young, impressionable, self that making it as a scientist was all about asking the right questions. But, the key constraint, was not just the ability to get ask the right question. Rather, it was the ability to have the right tools to answer the question experimentally.

As science has progressed, what we seek to measure, has become smaller and shorter-lived. The gravitational waves from the collision of a pair of black holes, detected by LIGO back in 2015, produced a displacement smaller than the diameter of a proton here on Earth. The machines built to measure that displacement cost something on the order of a billion dollars.

And that example has played out across the entire science waterfront. The phenomena, important as they are to moving science forward, remain ephemeral. You can ask exactly the right question, but the tools to answer your scientific query are expensive.

So why do science then? Aren’t there other more important policy objectives at hand? I would answer that we need to do science for two reasons: first, science delivers concrete practical goods like new medicines and therapies. And second, science allows us to gain knowledge about our place in the universe.

How to reform NIH…

Recently, I’ve mostly written in this respect about the NSF, but I also spent six years at the NIH, as a staff fellow in the intramural program (the biomedical medical center in Bethesda Maryland). When most folks think about the NIH, they are not really focussing on the intramural program. Rather, it’s the extramural program that gives out grant awards to biomedical researchers at US Colleges and Medical Centers that gets the attention. And I guess that’s fine because the extramural program represents about 90% of the NIH budget.

But, if I were going to magically reform the agency, I would focus on the intramural program. That’s because it has so much potential. With an annual budget north of $4B/year, America’s largest research medical center and thousands of young researchers from all over the world, it has so much potential. If Woods Hole is a summer nexus for life sciences during the summer, the NIH Bethesda campus is that thing on steroids year round.

The special sauce for the intramural program is that ideas can become experiments and then discoveries without the usual intermediate step of writing a proposal and waiting to see if it was funded. When I was at NIH, I could literally conceive of a new experiment, order the equipment and reagents and publish the results several months later. Hence, the intramural program has the structure in place to be a major science accelerator.

But, for some reason, when we think of such science accelerators, we generally consider private institutions like HHMI, the Allen Institutes and perhaps the Institute for Advanced Study in Princeton. What about NIH? On the criteria of critical mass, it dwarfs those places.

To my mind the problem lies in NIH’s ‘articles of confederation’ nature: it’s really 27 (or so) different Institutes and other units that are largely quite independent (especially the NCI), with a relatively weak central leadership. And this weak confederation organization plays out, not only on the Hill or in the awarding of extramural awards, but crucially also on the Bethesda campus, where intramural institute program directors rule fiefdoms that are more insular than academic units on a college campus. And this weak organizational architecture acts in the opposite direction of the science accelerator advantage that I wrote about above.

So here’s a big idea: let’s make the intramural program it’s own effective NIH institute. And have Congress authorize it and fund it separately, as a high risk, high payoff biomedical research program for the country. Does that sound like ARPA-H? Ooops. Well, then maybe we should just give the Bethesda campus to ARPA-H.